News & Updates Category
Today is the 50th anniversary of the Hyde Amendment, a budget rider that bars federal insurance programs from covering abortion care. Physicians for Reproductive Health President and CEO, Dr. Jamila Perritt, shares reflections.
As the Board Chair of a physician organization and a public health professional, I view the nomination of Dr. Heidi Overton as Commissioner of the Food and Drug Administration (FDA) to be nothing short of insulting to a public institution entrusted w...
Today, the Supreme Court of the United States issued its decision in West Virginia v. B.P.J. and Little v. Hecox, deeming it constitutional to ban transgender students from playing on school sports teams consistent with their gender identity.
Today, the Supreme Court of the United States issued its decision in Trump v. Barbara, affirming existing constitutional protections to birthright citizenship.
Today, Physicians for Reproductive Health is proud to share our Strategic Plan for the next five years, Fiscal Year 2027-2032. Dr. Jamila Perritt, ob/gyn in Washington DC and President & CEO of Physicians for Reproductive Health responds with a state...
Today is the fourth anniversary of the decision in Dobbs v. Jackson Women's Health Organization, a case that upended the legal framework for abortion access in the United States. The following is a joint statement from the National Abortion Federatio...
Today, Dr. Josephine Urbina, an ob/gyn in California and Fellow with Physicians for Reproductive Health, is testifying before the Democratic Women’s Caucus in a hearing titled “The Assault of Women By Trump’s ICE & CBP.”
Today, the Supreme Court of the United States continues to pause Louisiana's attempt to eliminate mifepristone via mail and for pick up at pharmacy while the litigation continues. Dr. Jamila Perritt, ob/gyn in Washington DC and President & CEO of Phy...
On May 5, 2026, Physicians for Reproductive Health, represented by Fried, Frank, Harris, Shriver & Jacobson LLP, filed an amicus brief to the Supreme Court of the United States detailing how critical it is for patients to be able to access mifepristo...
Today, a federal appeals court granted Louisiana’s motion in State of Louisiana et al v Food and Drug Administration, effective immediately. As a result, mifepristone via telehealth is no longer accessible for anyone seeking abortion care in the cou...
Together, we can build a future where no one goes without the health care they need. Donate today.
